Abstract
Around 50 % of the world’s population is at the risk of dengue, a viral infection. Presently, there are not many drugs and prophylactic measures available to control dengue viral infection, and hence, there is an urgent need to develop effective antidengue compound from natural sources. In the current study, we explored the antiviral properties of the medicinal plant Vetiveria zizanioides against dengue virus. Initially, the antiviral properties of active compounds were examined using docking analysis along with reference ligand. The enzyme–ligand complex which showed higher binding affinity than the reference ligand was employed for subsequent analysis. The stability of the top scoring enzyme–ligand complex was further validated using molecular simulation studies. On the whole, the study reveals that the compound Ethyl 4-(4-methylphenyl)-4-pentenoate has an effective antiviral property, which can serve as a potential lead molecule in drug discovery process.
Similar content being viewed by others
Abbreviations
- ADMET:
-
Absorption, distribution, metabolism, excretion, and toxicity
- CDC:
-
Centre for Disease Control and Prevention
- DENV:
-
Dengue virus
- LINCS:
-
Linear constraint solver
- MOLCAD:
-
Molecular computer-aided design
- NS:
-
Nonstructural
- NVT:
-
Constant number of particles, volume, and temperature
- NPT:
-
Constant number of particles, pressure, and temperature
- PDB:
-
Protein data bank
- PME:
-
Particle mesh Ewald
- RMSD:
-
Root mean square deviation
- RMSF:
-
Rood mean square fluctuation
- Vetiveria zizanioides :
-
V. zizanioides
References
Hynes, N. A. (2012). Dengue: A reemerging concern for travelers. Cleveland Clinic Journal of Medicine, 9, 7474–7482.
Tomlinson, S. M., & Watowich, S. J. (2011). Anthracene-based inhibitors of dengue virus NS2B–NS3 protease. Antiviral Research, 89, 127–135.
Wang, Q. Y., Patel, S. J., Vangrevelinghe, E., Xu, H. Y., Rao, R., Jaber, D., et al. (2009). A small-molecule Dengue virus entry inhibitor. Antimicrobial Agents and Chemotherapy, 53, 51823–51831.
Qing, M., Zou, G., Wang, Q. Y., Xu, H. Y., Dong, H., Yuan, Z., & Shi, P. Y. (2010). Characterization of Dengue virus resistance to Brequinar in cell culture. Antimicrobial Agents and Chemotherapy, 54, 3686–3695.
Gromowski, G. D., Barrett, N. D., & Barrett, A. D. T. (2008). Characterization of Dengue virus complex-specific neutralizing epitopes on envelope protein domain III of Dengue 2 virus. Journal of Virology, 82, 8828–8837.
Luo, D., Xu, T., Hunke, C., Gruber, G., Vasudevan, S. G., & Lescar, J. (2008). Crystal structure of N3 protease—helicase from dengue virus. Journal of Virology, 82, 173–183.
Wang, Q. Y., Kondreddi, R. R., Xie, X., Rao, R., Nilar, S., Xu, H. Y., et al. (2011). A translation inhibitor that suppresses Dengue virus in vitro and in vivo. Antimicrobial Agents and Chemotherapy, 55, 4072–4080.
Falgout, B., Pethel, M., Zhang, Y. M., & Lai, C. J. (1991). Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of Dengue virus nonstructural proteins. Journal of Virology, 65, 2467–2475.
Chambers, T. J., Nestorowicz, A., Amberg, S. M., & Rice, C. M. (1993). Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B–NS3 complex formation, and viral replication. Journal of Virology, 67, 6797–6807.
Wu, C. F., Wang, S. H., Sun, C. M., Hu, S. T., & Syu, W. J. (2003). Activation of dengue protease autocleavage at the NS2B–NS3 junction by recombinant NS3 and GST-NS2B fusion proteins. Journal of Virological Methods, 114, 45–54.
Tomlinson, S. M., Malmstrom, R. D., Russo, A., Mueller, N., Pang, Y. P., & Watowich, S. J. (2009). Structure-based discovery of dengue virus protease inhibitors. Antiviral Research, 82, 110–114.
Rates, S. M. K. (2001). Plants as source of drugs. Toxicon, 39, 603–613.
Lanini, J., Almeida, J. M. D., Nappo, S. A., & Carlini, E. A. (2012). Are medicinal herbs safe? The opinion of plant vendors from Diadema (Sao Paulo, southeastern Brazil). Revista Brasileira de Farmacognosia, 22, 21–28.
Kim, H., Chen, F., Wang, X., Chung, H. Y., & Jin, Z. (2005). Evaluation of antioxidant activity of vetiver (Vetiveria zizanioides L) oil and identification of its antioxidant activity constituents. Journal of Agriculture and Food Chemistry, 53, 7691–7695.
Singh, S. P., Sharma, S. K., Singh, T., & Singh, L. (2013). Review on Vetiveria zizanioides: A medicinal herb. JDDT, 1, 80–83.
Peng, H. Y., Lai, C. C., Lin, C. C., & Chou, S. T. (2014). Effect of Vetiveria zizanioides essential oil on melanogenesis in melanoma cells: Downregulation of tyrosinase expression and suppression of oxidative stress. The Scientific World Journal. doi:10.1155/2014/213013.
Maffei, M. (2002). Vetiveria: The genus vetiveria (p. 73). Boca Raton: CRC Press.
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., et al. (2000). The protein data bank. Nucleic Acid Research, 28, 235–242.
Chandramouli, S., Joseph, J. S., Daudenarde, S., Gatchalian, J., Ty, C. C., & Kuhn, P. (2010). Serotype-Specific structural differences in the protease-cofactor complexes of the dengue virus family. Journal of Virology, 84, 3059–3067.
Erbel, P., Schiering, N., D’Arch, A., Renatus, M., Kroemer, M., Lim, S. P., et al. (2006). Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nature Structural & Molecular Biology, 13, 372–373.
Noble, C. G., She, C. C., Chao, A. T., & Shi, P. Y. (2012). Ligand-bound structures of the dengue virus protease reveal the active conformation. Journal of Virology, 86, 438–446.
Luo, D., Wei, N., Daon, D. N., Paradkar, P. N., Chong, Y., Davidson, A. D., et al. (2010). Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications. Journal of Biological Chemistry, 285, 18817–18827.
Chou, S. T., Lai, C. P., Lin, C. C., & Shih, Y. (2012). Study of the chemical composition, antioxidant activity and anti-inflammatory activity of essential oil from Vetiveria zizanioides. Food Chemistry, 134, 262–268.
Frimayanthi, N., Chee, C. F., Zain, S. M., & Rahman, N. A. (2011). Design of new competitive Dengue Ns2b/Ns3 protease inhibitors—a computational approach. International Journal of Molecular Sciences, 12, 1089–1100.
Jain, A. N. (2003). Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry, 46, 499–511.
Jones, G., Willett, P., & Glen, R. C. (1995). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. Journal of Molecular Biology, 245, 43–53.
Meng, E. C., Shoichet, B. K., & Kuntz, I. D. (1992). Automated docking with grid-based energy evaluation. Journal of Computational Chemistry, 13, 505–524.
Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., & Mee, R. P. (1997). Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design, 11, 425–445.
Ling, B., Bi, S., Sun, M., Jing, Z., Li, X., & Zhang, R. (2014). Molecular dynamics simulations of mutated Mycobacterium tuberculosis l-alanine dehydrogenase to illuminate the role of key residues. Journal of Molecular Graphics and Modelling, 50, 61–70.
Hess, B., Kutzner, C., Spoel, D. V. D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and Scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435–447.
Lee, H. C., Hsu, W. C., Liu, A. L., Hsu, C. J., & Sun, Y. C. (2014). Using thermodynamic integration MD simulation to compute relative protein-ligand binding free energy of a GSK3β kinase inhibitor and its analogs. Journal of Molecular Graphics and Modelling, 51, 37–49.
Suhre, K., & Sanejouand, Y. H. (2015). ElNemo: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement. The Journal of Physical Chemistry B, 119, 15395–15406.
Spoel, D. V. D., Lindahl, E., Hess, B., & Groenhof, G. (2005). GROMACS: Fast, flexible and free. Journal of Computational Chemistry, 26, 1707–1718.
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., et al. (2012). admetSAR: A comprehensive source and free tool for evaluating chemical ADMET properties. Journal of Chemical Information and Modeling, 52, 3099–3105.
Lavanya, P., Ramaiah, S., & Anbarasu, A. (2015). Computational analysis reveal inhibitory action of nimbin against dengue viral envelope protein. Virus Disease, 26, 243–254.
Hao, G. F., Yang, G. F., & Zhan, C. G. (2012). Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem. Drug Discovery Today, 17, 1121–1126.
Badia, E., Oliva, J., Balaguer, P., & Cavailles, V. (2007). Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. Current Medicinal Chemistry, 14, 3035–3045.
Jenwitheesuk, E., & Samudrala, R. (2005). Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach. Antiviral Therapy, 10, 157–166.
Layten, M., Hornak, V., & Simmerling, C. (2006). The open structure of a multi-drug-resistant HIV-1 protease is stabilized by crystal packing contacts. Journal of the American Chemical Society, 128, 13360–13361.
Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007). Computational alanine scanning mutagenesis-an improved methodological approach. Journal of Computational Chemistry, 28, 644–654.
Senthilvel, P., Lavanya, P., Kumar, K. M., Swetha, R., Anitha, P., Bag, S., et al. (2013). Flavonoid from Carica papaya inhibits NS2B–NS3 protease and prevents Dengue 2 viral assembly. Bioinformation, 9, 18.
Tomlinson, S. M., Malmstrom, R. D., & Watowich, S. J. (2011). New approaches to structure-based discovery of dengue protease inhibitors. Infectious Disorders-Drug Targets, 9, 327–343.
Xie, X., Zou, J., Wang, Q. Y., Noble, C. G., Lescar, J., & Shi, P. Y. (2005). Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus. Virology, 450, 250–257.
Mishra, N. K., Deepak, R. N. V. K., Sankararamakrishnan, R., & Verma, S. (2015). Controlling in vitro insulin amyloidosis with stable peptide conjugates: A combined experimental and computational study. Journal of Physical Chemistry B, 119, 15395–15406.
Zhang, L., & Demain, A. L. (2005). Natural products: Drug discovery and therapeutic medicine. New York: Humana Press.
Lajiness, M. S., Vieth, M., & Erickson, J. (2004). Molecular properties that influence oral drug-like behavior. Current Opinion in Drug Discovery and Development, 7, 470–477.
Geldenshuys, W. J., Allen, D. D., & Bloomquist, J. R. (2012). Novel models for assessing blood–brain barrier drug permeation. Expert Opinion on Drug Metabolism & Toxicology, 8, 647653.
Alavijeh, M. S., Chishty, M., Qaiser, Z. M., & Palmr, A. M. (2005). Drug metabolism and pharmacokinetics, the blood–brain barrier, and central nervous system drug discovery. NeuroRx, 2, 554–571.
Artal, C. F. J., Wichmann, O., Farrar, J., & Gascon, J. (2013). Neurological complications of dengue virus infection. The Lancet Neurology, 12, 906–919.
Bohets, H., Annaert, P., Mannes, G., Beijsterveldt, L. V., Anciaux, K., Verboven, P., et al. (2001). Strategies for absorption screening in drug discovery and development. Current Topics in Medicinal Chemistry, 1, 367–383.
Bezirtzoglou, E. E. V. (2012). Intestinal chromosomes P450 regulating the intestinal microbiota and its probiotic profile. Microbial Ecology in Health and Disease. doi:10.3402/mehd.v23i0.18370.
Wessel, M. D., Jurs, P. C., Tolan, J. W., & Muskal, S. M. (1998). Prediction of human intestinal absorption of drug compounds from molecular structure. Journal of Chemical Information and Computer Sciences, 38, 726–735.
Acknowledgments
Dr. Anand Anbarasu and Dr. Sudha Ramaiah gratefully acknowledge the Indian Council of Medical Research (ICMR), Government of India Agency for the research grant [IRIS ID: 2014-0099]. P. Lavanya thanks ICMR for the Research fellowship. We would like to thank the management of VIT University for providing us the necessary facilities to carry out this research project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Lavanya, P., Ramaiah, S. & Anbarasu, A. Ethyl 4-(4-methylphenyl)-4-pentenoate from Vetiveria zizanioides Inhibits Dengue NS2B–NS3 Protease and Prevents Viral Assembly: A Computational Molecular Dynamics and Docking Study. Cell Biochem Biophys 74, 337–351 (2016). https://doi.org/10.1007/s12013-016-0741-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-016-0741-x